Posts Tagged Venture Capital

Follow the Money to Medical Device & Diagnostic Opportunities
Spotlight on VENITI, Inc.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. VENITI is a U.S. private company that develops devices for the management and treatment of venous insufficiency. It raised […]

Learn more

It’s Getting Harder for Bio/Pharma to Raise Money

by

Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) may not be feeling it yet, but the downturn in external financing for early stage bio/pharma companies is real. Two recent articles in the financial press underscore what has been happening. Bloomberg chronicled the challenges early stage public companies are facing as they go out for […]

Learn more

VC Funding Only Bright Spot in Depressed Financing Picture

by

Following two record fundraising years is a tough act, and 2016 is shaping up to be somewhat anti-climactic. The data in Figure 1 (below) demonstrates just how quickly the environment has changed since the heady days of 2015. CDMOs and CROs need to be concerned about what it implies for demand for their services. Venture […]

Learn more

Follow the Money to Medical Device & Diagnostic Opportunities
Spotlight on Organogenesis, Inc.

by

Follow the Money to Medical Device & Diagnostic Opportunities highlights a newly funded medical device or diagnostic company. This includes important insights into the featured company’s product pipeline, manufacturing and business relationships, and likely sourcing opportunities. Organogenesis is a private US company that focuses on regenerative medicine, specializing in bio-active wound healing, oral regeneration and […]

Learn more

CDMOs Cautiously Address Expansion

by

These are high times for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs). A record flood of external financing is flowing into the bio/pharmaceutical industry. Global bio/pharmaceutical companies are outsourcing more of their development activity, and FDA is being especially accommodating. R&D spending is growing, and the clinical development pipeline is really […]

Learn more

Big Jump in Early Phase Trials

by

Registrations of early phase clinical trials took a big jump in 2014, a clear sign that the flood of new money flowing into the bio/pharmaceutical industry is quickly being put to work. Registrations of Phase 1 clinical trials in clinical trials.gov jumped 42% in 2014 following two years of decline, and reached the highest level […]

Learn more